Labmaster timeline 1985-2010
2010: SITRA’s withdrawal and the company became privately owned 2010-11-29
2008: CECL Feasibility Study for Pharmaceutical company and immunoassay for AFP 2008-11-29
2007: CECL Feasibility Study for Pharmaceutical company with ultra-sensitive CRP 2007-11-29
2007: CECL Feasibility Study for Pharmaceutical company and antibody based test for one bacterium 2007-11-29
2006: CECL Feasibility Study for Pharmaceutical company and drug testing 2006-11-29
2005: Labmaster PCR Amplification Kits and dry PCR mix were launched 2005-11-29
2004: in MEDICA 2004 Labmaster’s own feasibility study on ultra-sensitive CRP assay 2004-11-29
2004: in MEDICA 2004 Labmaster’s own feasibility study on ultra-sensitive CRP assay was presented
2003: Labmaster Troponin I ELISA IVD kit was launched 2003-11-29
Labmaster Troponin I ELISA IVD kit was launched and CE-marked in year 2005
2003: Labmaster brought onto the market Stable Troponin I antigen 2003-11-29
Labmaster started manufacturing of unique products line of Phytoestrogen TR-FIA immunodiagnostic kits designed for the research of the dietary health
2002: Labmaster started sales of PPase soluble inorganic pyrophosphatase 2002-11-29
2001: The cathodic electrochemiluminescence (CECL) project, PEKLA, started in Labmaster 2001-11-29
1999: Enzyme linked immunosorbent assay for detection of nanobacteria was manufactured 1999-11-29
1998: Labmaster stared to developed the panel for cardiac markers 1998-11-29
Labmaster sold the clinical laboratory operations and started distribution of Cheshire Diagnostics Ltd - Autoimmuno diseases kit panel (e.g. Anti-Cardiolipin IgG, IgM & IgA ELISA) and later also Osteometer BioTech A/S osteoporosis kits
1991: Labmaster manufactured OEM products 1991-11-29
In 1991 Labmaster manufactured OEM products, such as streptavidin coated -plates and DELFIA CRP Kits
1990: The IVD ELISA kit production was started 1990-11-29
The IVD ELISA kit production was started with Total IgE, continued ß-2-Microglobulin, and later additions Anti-gliadin IgG and IgA, become the main products
1986: Monoclonal antibody production was started 1986-11-29
Monoclonal antibody production was started for IgE, ß2M, CRP and PLA2
1985: Labmaster ltd, clinical research laboratory, was founded 1985-11-25